scispace - formally typeset
M

Markku Miettinen

Researcher at National Institutes of Health

Publications -  179
Citations -  13900

Markku Miettinen is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Vimentin & Sarcoma. The author has an hindex of 60, co-authored 179 publications receiving 12719 citations. Previous affiliations of Markku Miettinen include New York University & Thomas Jefferson University Hospital.

Papers
More filters
Journal ArticleDOI

Gastrointestinal stromal tumors: recent advances in understanding of their biology.

Markku Miettinen, +5 more
- 01 Oct 1999 - 
TL;DR: The cell of origin is not fully understood, but resemblance to the interstitial cells of Cajal, expression of some smooth muscle markers, and occurrence outside of the GI-tract suggest origin from multipotential cells that can differentiate into Cjal and smooth muscle cells.
Journal Article

CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34

Maarit Sarlomo-Rikala, +3 more
- 01 Aug 1998 - 
TL;DR: Results indicate that CD117 is a specific marker for GIST among tumors that occur in the GI tract and adjacent regions, and separates GISTs from true leiomyomas and gastric schwannomas.
Journal ArticleDOI

Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas

Markku Miettinen, +2 more
- 01 Feb 1995 - 
TL;DR: It is shown that gastrointestinal mesenchymal tumors can be immunophenotypically divided in categories that correlate with light microscopically defined diagnostic entities, namely typical leiomyomas, schwannomas, and GIST, most cases of the latter representing tumors of primitive meschymal cells that are CD34 positive.
Journal ArticleDOI

GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.

Markku Miettinen, +10 more
- 01 Jan 2014 - 
TL;DR: GATA3 is a useful marker in the characterization of not only mammary and urothelial but also renal and germ cell tumors, mesotheliomas, and paragangliomas, which sets these tumors apart from epithelial neuroendocrine tumors.
Journal ArticleDOI

Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites

Cheryl A. Hanau, +1 more
- 01 Apr 1995 - 
TL;DR: It is concluded that SFT is a neoplasm of fibroblasts/primitive mesenchymal cells with features of multidirectional differentiation, and the finding of a novel site for SFT, the parotid gland is reported.